Posted by Joseph Griffin on Nov 21st, 2024
Sutro Biopharma, Inc. (NASDAQ:STRO – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 EPS estimates for Sutro Biopharma in a research note issued on Monday, November 18th. HC Wainwright analyst...
More of this article »